Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
出版年份 2012 全文链接
标题
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
作者
关键词
-
出版物
JOURNAL OF NEURO-ONCOLOGY
Volume 108, Issue 3, Pages 491-498
出版商
Springer Nature
发表日期
2012-03-18
DOI
10.1007/s11060-012-0847-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme
- (2014) Paul Sanghera et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Treatment of Glioblastoma Multiforme with Radiotherapy and Concomitant and Adjuvant Temozolomide: Translation of Randomised Controlled Trial Evidence into Routine Clinical Practice
- (2011) C. Herbert et al. CLINICAL ONCOLOGY
- Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy
- (2011) Whitney B. Pope et al. Current Neurology and Neuroscience Reports
- Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab
- (2011) B. M. Ellingson et al. NEURO-ONCOLOGY
- Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?
- (2010) Michael Weller et al. Future Oncology
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative MR in multi-center clinical trials
- (2010) Edward Ashton JOURNAL OF MAGNETIC RESONANCE IMAGING
- Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity
- (2010) Benjamin M. Ellingson et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons
- (2010) Devyani Bedekar et al. MAGNETIC RESONANCE IN MEDICINE
- Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
- (2010) M. Prados et al. NEURO-ONCOLOGY
- ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
- (2010) Martha Nowosielski et al. NEURORADIOLOGY
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Pseudoprogression and pseudoresponse in the treatment of gliomas
- (2009) Dieta Brandsma et al. CURRENT OPINION IN NEUROLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker
- (2009) Rajan Jain et al. JOURNAL OF NEURO-ONCOLOGY
- Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
- (2009) Whitney B. Pope et al. RADIOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation